Sebastian Waldstein, None;
Christian Simader, None;
Giovanni Staurenghi, Alcon (C), Allergan (C), Bayer (C), Boehringer (C), Carl Zeiss Meditec (C), Genentech (C), GSK (C), Heidelberg Engineering (C), Heidelberg Engineering (F), Novartis (C), Ocular Instruments (P), OD-OS (C), OD-OS (F), Optos (C), Optos (F), QLT (C), Quentel Medical (C), Quentel Medical (F), Roche (C);
Michael Larsen, Alcon (F), Allergan (F), Bayer (F), GlaxoSmithKline (F), Novartis (C), Novartis (F), Pfizer (C), Pfizer (F), Thrombogenics (C);
Paul Mitchell, Bayer (C), Novartis (C), Pfizer (C);
Ursula Schmidt-Erfurth, Alcon (C), Bayer (C), Boehringer (C), Novartis (C)